SCHEMBL30469897

SCHEMBL30469897

COc1ncc(NC(=O)C(=O)N2C[C@@H](C)CC[C@@H]2C2CCCC2)cc1C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 20/20 0.46
▸ WDR77 Q9BQA1 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30470156 1.00 PRMT5 (0.46) PRMT5WDR77
SCHEMBL29326250 1.00 PRMT5 (0.46) PRMT5WDR77
SCHEMBL30469557 1.00 PRMT5 (0.46) PRMT5WDR77
SCHEMBL24367761 1.00 PRMT5 (0.46) PRMT5WDR77
SCHEMBL24367354 1.00 PRMT5 (0.46) PRMT5WDR77
SCHEMBL24364045 1.00 PRMT5 (0.46) PRMT5WDR77
SCHEMBL24364041 1.00 PRMT5 (0.46) PRMT5WDR77
SCHEMBL24364042 1.00 PRMT5 (0.46) PRMT5WDR77
SCHEMBL30470639 1.00 PRMT5 (0.46) PRMT5WDR77
SCHEMBL24367387 0.99 PRMT5 (0.47) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4188920-A1 PIPERIDIN-1-YL-N-PYRYDINE-3-YL-2-OXOACETAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF MTAP-DEFICIENT AND/OR MTA-ACCUMULATING CANCERS Tango Therapeutics, Inc. (US) 2023-06-07 — — EP disclosed
Send feedback